322 results on '"Siddiqui, Mohammad S"'
Search Results
2. Fibrosis Progression Rate in Biopsy-Proven Nonalcoholic Fatty Liver Disease Among People With Diabetes Versus People Without Diabetes: A Multicenter Study
3. Differential fuel utilization in liver transplant recipients and its relationship with non‐alcoholic fatty liver disease
4. Liver and cardiovascular disease outcomes in metabolic syndrome and diabetic populations: Bi-directional opportunities to multiply preventive strategies
5. Validation of the accuracy of the FAST™ score for detecting patients with at-risk nonalcoholic steatohepatitis (NASH) in a North American cohort and comparison to other non-invasive algorithms
6. Fibrosis Progression Rate in Biopsy-Proven Nonalcoholic Fatty Liver Disease Among People With Diabetes Versus People Without Diabetes: A Multicenter Study
7. Hepatic, Extra-hepatic Outcomes and Causes of Mortality in NAFLD – An Umbrella Overview of Systematic Review of Meta-Analysis
8. A Pilot Genome‐Wide Analysis Study Identifies Loci Associated With Response to Obeticholic Acid in Patients With NASH
9. Factors Impacting Survival in Those Transplanted for NASH Cirrhosis: Data From the NailNASH Consortium
10. A double-blind randomized placebo-controlled trial of albumin in outpatients with hepatic encephalopathy: HEAL study
11. Comparative accuracy of endosonographic shear wave elastography and transcutaneous liver stiffness measurement: a pilot study
12. Diagnostic Accuracy of Noninvasive Fibrosis Models to Detect Change in Fibrosis Stage
13. Vibration-Controlled Transient Elastography to Assess Fibrosis and Steatosis in Patients With Nonalcoholic Fatty Liver Disease
14. Aldafermin in patients with non-alcoholic steatohepatitis (ALPINE 2/3): a randomised, double-blind, placebo-controlled, phase 2b trial
15. Derivation and Validation of a Model to Predict Clinically Significant Portal Hypertension Using Transient Elastography and FIB-4
16. Performance characteristics of vibration‐controlled transient elastography for evaluation of nonalcoholic fatty liver disease
17. Liver Transplant Is Associated with Sustained Improvement in Tandem Gait and Risk of Falls
18. Use of Telehealth Expedites Evaluation and Listing of Patients Referred for Liver Transplantation
19. Immune Activation Mediates the Association of Advanced Hepatic Fibrosis With Adverse Outcomes in Patients With Coronary Artery Disease
20. Discordant association of nonalcoholic fatty liver disease with lipoprotein(a) and markers of atherogenic dyslipidemia
21. Office-Based Weight Loss Counseling Is Ineffective in Liver Transplant Recipients
22. Diagnostic Accuracy of Noninvasive Fibrosis Models to Detect Change in Fibrosis Stage
23. Low and High Birth Weights Are Risk Factors for Nonalcoholic Fatty Liver Disease in Children
24. COMBINED HEART-LIVER TRANSPLANTATION: SINGLE CENTER EXPERIENCE
25. Proton Pump Inhibitor Initiation and Withdrawal affects Gut Microbiota and Readmission Risk in Cirrhosis
26. Examining the interim proposal for name change to steatotic liver disease in the US population
27. Non-alcoholic Fatty Liver Disease in Non-obese Patients
28. Severity of Nonalcoholic Fatty Liver Disease and Progression to Cirrhosis Are Associated With Atherogenic Lipoprotein Profile
29. Hepatic, Extra-hepatic Outcomes and Causes of Mortality in NAFLD – An Umbrella Overview of Systematic Review of Meta-Analysis
30. Endoscopic Cyanoacrylate Injection with Post-injection Audible Doppler Assessment of Gastric Varices: A Single-Institution Experience
31. Symptom Domain Groups of the Patient-Reported Outcomes Measurement Information System Tools Independently Predict Hospitalizations and Re-hospitalizations in Cirrhosis
32. Readmission rates and risk factors associated with emergency surgeries
33. Postoperative association between impaired renal function and vascular dysfunction in liver transplant recipients
34. Meta-analysis of the Placebo and Nocebo effects associated with Placebo treatment in randomized trials of lipid-lowering therapies
35. Diagnosis of Covert Hepatic Encephalopathy Without Specialized Tests
36. The presence and severity of nonalcoholic steatohepatitis is associated with specific changes in circulating bile acids
37. The patient buddy app can potentially prevent hepatic encephalopathy‐related readmissions
38. Meta-analysis of the Placebo and Nocebo effects associated with Placebo treatment in randomized trials of lipid-lowering therapies
39. Differential fuel utilization in liver transplant recipients and its relationship with non-alcoholic fatty liver disease
40. Weight Gain, Fibroblast Growth Factor‐23, and Vascular Function in Liver Transplant Recipients
41. Sex Differences in Vascular Endothelial Function After Liver Transplant
42. Nonalcoholic Steatohepatitis (NASH) Is Associated with a Decline in Pancreatic Beta Cell (β-Cell) Function
43. Post-Transplant Biliary Strictures: An Updated Review
44. Nonalcoholic fatty liver disease
45. Editorial: targeting aberrant hepatic inflammation for treatment of non‐alcoholic steatohepatitis
46. Early laboratory values after liver transplantation are associated with anastomotic biliary strictures
47. Derivation and Validation of a Model to Predict Clinically Significant Portal Hypertension Using Transient Elastography and FIB-4
48. Enhancement of functional connectivity, working memory and inhibitory control on multi-modal brain MR imaging with Rifaximin in Cirrhosis: Implications for the gut-liver-brain axis
49. Abstract 14367: Elevated Creatinine Levels Are Associated With Vascular Dysfunction in Liver Transplant Recipients
50. Effect of delayed elective surgeries during COVID-19 pandemic
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.